APA

Sharma R., Litchfield J., Bergman A., Atkinson K., Kazierad D., Gustavson S. M., Di L., Pfefferkorn J. A. & Kalgutkar A. S. (20151124). Comparison of the circulating metabolite profile of PF-04991532, a hepatoselective glucokinase activator, across preclinical species and humans: potential implications in metabolites in safety testing assessment. : Drug metabolism and disposition: the biological fate of chemicals.

Chicago

Sharma Raman, Litchfield John, Bergman Arthur, Atkinson Karen, Kazierad David, Gustavson Stephanie M, Di Li, Pfefferkorn Jeffrey A and Kalgutkar Amit S. 20151124. Comparison of the circulating metabolite profile of PF-04991532, a hepatoselective glucokinase activator, across preclinical species and humans: potential implications in metabolites in safety testing assessment. : Drug metabolism and disposition: the biological fate of chemicals.

Harvard

Sharma R., Litchfield J., Bergman A., Atkinson K., Kazierad D., Gustavson S. M., Di L., Pfefferkorn J. A. and Kalgutkar A. S. (20151124). Comparison of the circulating metabolite profile of PF-04991532, a hepatoselective glucokinase activator, across preclinical species and humans: potential implications in metabolites in safety testing assessment. : Drug metabolism and disposition: the biological fate of chemicals.

MLA

Sharma Raman, Litchfield John, Bergman Arthur, Atkinson Karen, Kazierad David, Gustavson Stephanie M, Di Li, Pfefferkorn Jeffrey A and Kalgutkar Amit S. Comparison of the circulating metabolite profile of PF-04991532, a hepatoselective glucokinase activator, across preclinical species and humans: potential implications in metabolites in safety testing assessment. : Drug metabolism and disposition: the biological fate of chemicals. 20151124.